Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

25.30
Delayed Data
As of Feb 24
 -0.05 / -0.20%
Today’s Change
12.15
Today|||52-Week Range
27.95
+0.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues42.7M44.2M51.6M56.8M
 
 
 
 
 
Cost of Goods Sold2.5M1.6M2.1M2.8M
 
 
 
 
 
Depreciation And Amortization270.0K429.0K688.0K600.0K
 
 
 
 
 
 
Operating ExpensesGross Income39.9M42.2M48.9M53.4M
 
 
 
 
 
General Expenses33.0M35.7M37.2M33.5M
 
 
 
 
 
Research And Development9.4M10.6M11.1M7.9M
 
 
 
 
 
Total Operating Expenses35.8M37.8M40.0M37.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.8M6.4M11.6M19.8M
 
 
 
 
 
Extraordinary Credit189.0K101.0K123.0K125.0K
 
 
 
 
 
Extraordinary Charge---382.0K0.000.00
 
 
Interest Expense On Debt225.0K1.5M1.5M1.2M
 
 
 
 
 
Other Expenses8.0K-4.0K2.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.0M5.0M10.7M19.1M
 
 
 
 
 
Income Taxes-174.0K-200.0K-405.0K-42.7M
 
 
 
 
 
Net Income6.9M4.8M10.3M61.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.9M49.2M49.4M49.5M
 
 
 
 
 
Shares To Calculate EPS Diluted49.6M51.2M51.7M52.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14$0.08$0.18$1.18
 
 
 
 
 
EPS Diluted$0.14$0.08$0.18$1.18